从高级白内障手术市场报告(2025年):2024年到2030年前几名13个国家的分析
市场调查报告书
商品编码
1849630

从高级白内障手术市场报告(2025年):2024年到2030年前几名13个国家的分析

2025 Premium Cataract Surgery Market Report: Analysis of the Top 13 Countries for 2024 to 2030

出版日期: | 出版商: Market Scope, LLC | 英文 | 商品交期: 最快1-2个工作天内

价格
简介目录

最新发布

"高端白内障手术市场报告(2025)" 提供了13个主要国家/地区过去七年的历史数据以及未来五年的预测数据,涵盖了后房型人工水晶体(PC-IOL)、散光矫正型人工水晶体(Toric IOL)和飞秒雷射辅助等内障手术(FLACSS)

本版本新增了多项分析,旨在为策略决策提供指导,包括PCS推广策略、外科医生招募模式、高端人工水晶体选择方法,以及自2005年以来LASIK术后和高端人工水晶体手术量,从而揭示推动PCS需求的人口统计因素。

该报告还涵盖了市场趋势,例如韩国和日本的PCS手术復苏、Lensar Ally等新型飞秒雷射辅助白内障手术(FLACS)的影响、包括婴儿潮一代推动屈光性晶状体置换术在内的人口结构变化,以及增长最快的优质人工晶状体扩张——RxSight

"高阶白内障手术市场报告(2025)" 清楚展现了全球主要的PCS市场,涵盖13个国家,这些国家占全球PCS製造商收入的84%。从美国和中国到日本、德国和其他国家,每个市场都得到了详细分析,重点介绍了关键趋势、成长驱动因素和战略机会。

本报告重点关注对评估市场潜力或计划推出关键白内障手术设备的公司而言最重要的因素,并提供实用见解以指导投资和扩张决策。

内容

高阶白内障手术市场报告(2025) 对全球高阶白内障手术市场进行了全面研究,揭示了关键趋势、市场动态以及企业和供应商的策略机会。本报告结合全球洞察和深入的国别分析,旨在指导企业在这个快速发展的市场中进行决策和投资。

主要亮点包括:

  • 高端人工水晶体和技术老花眼矫正、散光矫正、中距离优化、术后可调节人工水晶体、飞秒雷射辅助白内障手术(FLACS)雷射和弧形切口、手动分离边缘松解切口以及准分子雷射人工水晶体增强。
  • 主要市场概况:美国、中国、日本、法国、德国、巴西、加拿大、印度、西班牙、韩国、澳洲、英国和义大利这13个最大的白内障手术(PCS)市场的详细概览和摘要整理。
  • 市场和财务分析:各国白内障手术量预测、製造商收入、医疗机构收入以及公立和私立白内障手术方案的成本比较。
  • 医疗机构与外科医师洞察:各主要市场中,按外科医师划分的白内障手术量细分,包括单纯白内障手术、白内障/屈光手术以及单纯屈光手术。
  • 竞争格局:各国及全球製造商的收入占有率,以及最重要的白内障眼科医院和诊所清单。
  • 新兴市场:以市场规模排名的六个最重要的白内障手术国家概览。

信息图形


简介目录

What's New:

The "2025 Premium Cataract Surgery Market Report" provides an updated, expanded view of the world's top PCS markets, providing seven years of historical data and five-year forecasts for PC-IOL, toric IOL, and FLACS procedures across 13 key countries.

This edition adds new analyses to guide strategic decisions, including PCS promotion strategies, surgeon adoption patterns, and premium IOL selection methodologies, along with post LASIK and premium IOL surgery volumes since 2005 to highlight the population driving PCS demand.

The report also covers market trends such as the recovery of PCS procedures in South Korea and Japan, the impact of new FLACS lasers like the Lensar Ally, demographic drivers including baby boomers fueling refractive lens exchange, and the fastest-growing premium IOL, the RxSight post-op adjustable lens, expanding into Canada, South Korea, and Singapore.

The "2025 Premium Cataract Surgery Market Report" delivers a clear view of the world's leading PCS markets, covering 13 countries that together generate 84 percent of global PCS manufacturer revenue. From the United States and China to Japan, Germany, and beyond, each market is analyzed in depth, highlighting key trends, growth drivers, and strategic opportunities.

The report zeroes in on the factors that matter most for companies evaluating market potential or planning to launch premium cataract surgery devices, providing actionable insights to guide investment and expansion decisions.

Contents:

The "2025 Premium Cataract Surgery Market Report" offers a comprehensive look at the global PCS landscape, highlighting key trends, market dynamics, and strategic opportunities for companies and providers. The report combines global insights with deep, country-level analysis to guide decision-making and investment in this rapidly evolving market.

Key highlights include:

  • Premium IOLs and technologies: Presbyopia-correcting, toric, intermediate-optimized, and post-op adjustable lenses; FLACS lasers and arcuate incisions; manual limbal relaxing incisions; and excimer IOL enhancements.
  • Top market profiles: In-depth snapshots and executive summaries for the 13 largest PCS markets-United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.
  • Market and financial analysis: Country-specific forecasts for PCS procedures, manufacturer revenue, and provider revenue; cost comparisons for public and private cataract surgery options.
  • Provider and surgeon insights: Breakdown of PCS procedures by cataract-only, cataract/refractive, and refractive-only surgeons in each key market.
  • Competitive landscape: Manufacturer revenue shares by country and globally, plus a listing of the most important PCS eye hospitals and clinics.
  • Emerging markets: Overview of the next six most significant PCS countries ranked by market size.

INFOGRAPHICS